Hospital Aquired Infection (HAI): a cost-efficacy case study
AbstractThis study proposes a cost-effectiveness analysis concerning the implementation of a tool to check for ventilator-associated pneumonia (VAP) in Intensive Care. VAP is a sub-type of hospital-acquired pneumonia which occurs in people receiving mechanical ventilation. An empirical analysis is performed to estimate the effectiveness of a specific procedure to prevent VAP (i.e. Ventilator Bundle), as well as to evaluate cost savings related to not developing the infection. The relevance of the results thus obtained is not only clinical but also managerial and economic, since a reduction in costs improves the economic performance of hospitals and a lower incidence of VAP improves their reputation on the national market of healthcare services.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Institute for Economic Research on Firms and Growth - Moncalieri (TO) in its series CERIS Working Paper with number 201318.
Length: 25 pages
Date of creation: Dec 2013
Date of revision:
Ventilator-associated pneumonia; Ventilator Bundle; Analysis of cost-effectiveness; Intensive-Care Unit;
Find related papers by JEL classification:
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
This paper has been announced in the following NEP Reports:
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Enrico Viarisio) or (Anna Perin) or (Giancarlo Birello).
If references are entirely missing, you can add them using this form.